immunotherapy

Merck to buy immunotherapy developer Immune Design for $300 million
Merck to buy immunotherapy developer Immune Design for $300 million
Reuters
Merck
Immune Design
M&A
immunotherapy
Flag link:
After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck
After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck
Endpoints
GSK
Merck KGaA
Tesaro
immunotherapy
Flag link:
Five Things To Look Out For In Cancer Research In 2019
Five Things To Look Out For In Cancer Research In 2019
Forbes
cancer
R&D
immunotherapy
liquid biopsy
microbiome
side effects
Flag link:
Not So Fast With Immune Therapy For Breast Cancer
Not So Fast With Immune Therapy For Breast Cancer
Forbes
breast cancer
immunotherapy
Roche
Flag link:
CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients
CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients
CP Wire
CytoReason
immunotherapy
machine learning
Flag link:
CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients
CytoReason
immunotherapy
Flag link:
T-cell therapy for eradicating HIV reservoirs proves safe in small study
T-cell therapy for eradicating HIV reservoirs proves safe in small study
Fierce Biotech
HIV
immunotherapy
Flag link:
Sanofi says on track to regain solid position in cancer drugs
Sanofi says on track to regain solid position in cancer drugs
Reuters
Sanofi
oncology
immunotherapy
molecular oncology
cemiplimab
Flag link:
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
CP Wire
Advaxis
ADXS-NEO
immunotherapy
non-small cell lung cancer
clinical trials
Flag link:
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
Advaxis
ADXS-NEO
immunotherapy
Flag link:
Advaxis cuts staff as it seeks partner for troubled cancer vaccine
Advaxis cuts staff as it seeks partner for troubled cancer vaccine
Fierce Biotech
Advaxis
layoffs
vaccines
axalimogene filolisbac
cancer vaccines
immunotherapy
Flag link:
A new cancer care dilemma: Patients want immunotherapy even when evidence is lacking
A new cancer care dilemma: Patients want immunotherapy even when evidence is lacking
Stat
patients
cancer
immunotherapy
Flag link:
FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers
FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers
CP Wire
Turnstone Biologics
MG1
immunotherapy
MG1-HPV
Flag link:
FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers
Turnstone Biologics
MG1
immunotherapy
Flag link:
Early Observations From Aduro Biotech's pLADD Immunotherapy Look Promising
Early Observations From Aduro Biotech's pLADD Immunotherapy Look Promising
CP Wire
pLADD
immunotherapy
Aduro BioTech
metastatic colorectal cancer
Flag link:
Novartis, Harvard team up to develop immunotherapy drug-delivery systems
Novartis, Harvard team up to develop immunotherapy drug-delivery systems
Drug Delivery Business News
Novartis
Harvard
immunotherapy
drug delivery
R&D
immuno-oncology
Flag link:
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
Endpoints
immunotherapy
psoriasis
Escalier
R&D
Flag link:
Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Drug Delivery Business News
Inovio
ApolloBio
HPV
immunotherapy
Flag link:
Nanotech, immunotherapy combo vaccinates mouse against cancer
Nanotech, immunotherapy combo vaccinates mouse against cancer
Drug Delivery Business News
nanotech
immunotherapy
vaccines
cancer
Flag link:
Making the Promise of Immunotherapeutics into Reality
Making the Promise of Immunotherapeutics into Reality
Elsevier
immunotherapy
cancer
Flag link:

Pages